These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1092 related items for PubMed ID: 26088895

  • 21. Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects.
    Davis JD, Hackman F, Layton G, Higgins T, Sudworth D, Weissgerber G.
    Br J Clin Pharmacol; 2008 Apr; 65 Suppl 1(Suppl 1):68-75. PubMed ID: 18333868
    [Abstract] [Full Text] [Related]

  • 22. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R, Rosillon D, Bridson WE, Meeus MA, Salas E, Stockis A.
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [Abstract] [Full Text] [Related]

  • 23. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.
    Wang Z, Grasela DM, Krishna G.
    Clin Ther; 2007 Jun; 29(6):1098-106. PubMed ID: 17692724
    [Abstract] [Full Text] [Related]

  • 24. Vigabatrin Lacks Proarrhythmic Potential: Results from a Thorough QT/QTc Study in Healthy Volunteers.
    Tolbert D, Reid S, Harris S, Bekersky I.
    Clin Ther; 2017 Aug; 39(8):1639-1648. PubMed ID: 28668627
    [Abstract] [Full Text] [Related]

  • 25. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
    de Kam PJ, van Kuijk J, Smeets J, Thomsen T, Peeters P.
    Int J Clin Pharmacol Ther; 2012 Aug; 50(8):595-604. PubMed ID: 22735462
    [Abstract] [Full Text] [Related]

  • 26. A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects.
    Mondal SA, Assaf M, Liu L, O'Mara E.
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):251-8. PubMed ID: 26754679
    [Abstract] [Full Text] [Related]

  • 27. A Randomized Trial to Assess the Effect of Doravirine on the QTc Interval Using a Single Supratherapeutic Dose in Healthy Adult Volunteers.
    Khalilieh SG, Yee KL, Fan L, Liu R, Heber W, Dunzo E, Triantafyllou I, Hussaini A, Iwamoto M.
    Clin Drug Investig; 2017 Oct; 37(10):975-984. PubMed ID: 28785879
    [Abstract] [Full Text] [Related]

  • 28. Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women.
    Stier B, Fossler M, Liu F, Caltabiano S.
    Clin Ther; 2015 Jul 01; 37(7):1541-54. PubMed ID: 26138866
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel.
    Ettinger AB, LoPresti A, Yang H, Williams B, Zhou S, Fain R, Laurenza A.
    Epilepsia; 2015 Aug 01; 56(8):1252-63. PubMed ID: 26140524
    [Abstract] [Full Text] [Related]

  • 31. Thorough QTc Evaluation and the Safety of Supratherapeutic Doses of Odanacatib in Healthy Subjects.
    McCrea J, Mostoller K, Mahon C, Liu C, Liu F, Zajic S, Panebianco D, Chakravarthy M, Brandquist C, Gutierrez M, Stoch SA.
    Clin Pharmacol Drug Dev; 2019 Oct 01; 8(7):861-870. PubMed ID: 31175709
    [Abstract] [Full Text] [Related]

  • 32. Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study.
    Hulhoven R, Rosillon D, Letiexhe M, Meeus MA, Daoust A, Stockis A.
    Eur J Clin Pharmacol; 2007 Nov 01; 63(11):1011-7. PubMed ID: 17891537
    [Abstract] [Full Text] [Related]

  • 33. Ipragliflozin does not prolong QTc interval in healthy male and female subjects: a phase I study.
    Zhang W, Smulders R, Abeyratne A, Dietz A, Krauwinkel W, Kadokura T, Keirns J.
    Clin Ther; 2013 Aug 01; 35(8):1150-1161.e3. PubMed ID: 23910665
    [Abstract] [Full Text] [Related]

  • 34. Effect of intravenous zanamivir on cardiac repolarization.
    Lou Y, Gan J, Peppercorn A, Gould E, Weller S, Piscitelli SC, Patel P.
    Pharmacotherapy; 2013 Jul 01; 33(7):701-9. PubMed ID: 23553534
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A thorough QT/QTc study of the effect of fasiglifam, a GPR40 agonist, on cardiac repolarization in healthy adults.
    Lee RD, Nudurupati S, Marcinak J, Viswanathan P.
    Clin Pharmacol Drug Dev; 2015 Jul 01; 4(3):175-83. PubMed ID: 27140797
    [Abstract] [Full Text] [Related]

  • 39. Cardiac repolarization with Gabapentin enacarbil in a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.
    Davy M, Upward J, Arumugham T, Twomey C, Chen C, Stier B.
    Clin Ther; 2013 Dec 01; 35(12):1964-74. PubMed ID: 24290737
    [Abstract] [Full Text] [Related]

  • 40. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304.
    French JA, Krauss GL, Biton V, Squillacote D, Yang H, Laurenza A, Kumar D, Rogawski MA.
    Neurology; 2012 Aug 07; 79(6):589-96. PubMed ID: 22843280
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.